Notice Information
Notice Title
Drug Development Framework
Notice Description
Cardiff University are ranked 2nd nationally for the impact of their research and are among the top five universities in the UK for research excellence. Cardiff University has a thriving and innovative research culture, with research that has real impact and makes a positive difference to the world. As part of this, the University is translating fundamental discoveries in disease processes to develop new medicines to meet unmet clinical needs. Cardiff University is looking for companies with an innovative outlook and recognised expertise in supporting drug-discovery projects from early screening (electrophysiology and in vitro DMPK) to delivering de-risked novel molecules to clinical trials. Successful companies will be committed to the principles of the NC3Rs and will add value to our work by providing high-quality data for informing the drug-discovery pipeline.
Lot Information
Electrophysiology Services
We require providers for electrophysiology services relevant to neuroscience drug development. Currently we require validated ion channel assays for GABAA and NMDA modulators, on an automated electrophysiology platform, with QC and report generation. In the near future, it is likely we will require a range of other ion channel assays, as well as manual patch clamp services. We may also want to purchase ion channel expressing cell lines (under a MTA).
In-vivo assaysWe require providers for in-vivo assays, most usually with oral administration. We currently require reliable assays for pro-cognitive and anxiolytic effects. In the future, we may require assays to demonstrate other drug modulated effects, such as, but not limited to, an anti-depressive effect.
In-vitro drug metabolism (ADME-Tox) servicesWe require providers of in-vitro drug metabolism (ADME-Tox) services as part of our drug development pipeline. This includes, but is not limited to, measures of metabolism, permeability and transporters, physicochemical properties, protein binding and toxicology.
In-vivo pharmacokinetics (PK) and toxicologyWe require providers of in-vivo drug metabolism (ADME-Tox) services as part of our drug development pipeline.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-028b65
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/001039-2021
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
73 - Research and development services and related consultancy services
-
- CPV Codes
73111000 - Research laboratory services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 19 Jan 20215 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 19 Jan 20215 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Cancelled
- Lots Status
- Cancelled
- Awards Status
- Unsuccessful
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- CARDIFF UNIVERSITY
- Additional Buyers
- Contact Name
- Not specified
- Contact Email
- buyline@cardiff.ac.uk
- Contact Phone
- +44 2920879648
Buyer Location
- Locality
- CARDIFF
- Postcode
- CF24 0DE
- Post Town
- Cardiff
- Country
- Wales
-
- Major Region (ITL 1)
- TLL Wales
- Basic Region (ITL 2)
- TLL5 South East Wales
- Small Region (ITL 3)
- TLL52 Cardiff and Vale of Glamorgan
- Delivery Location
- TLL22 Cardiff and Vale of Glamorgan
-
- Local Authority
- Cardiff
- Electoral Ward
- Adamsdown
- Westminster Constituency
- Cardiff East
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-028b65-2021-01-19T10:24:02Z",
"date": "2021-01-19T10:24:02Z",
"ocid": "ocds-h6vhtk-028b65",
"description": "Bidders will need to create an account via In-Tend (https://in-tendhost.co.uk/cardiffuniversity/aspx/Home) in order to view the tender documents. (WA Ref:107445)",
"initiationType": "tender",
"tender": {
"id": "CU258",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Drug Development Framework",
"status": "cancelled",
"classification": {
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
},
"mainProcurementCategory": "services",
"description": "Cardiff University are ranked 2nd nationally for the impact of their research and are among the top five universities in the UK for research excellence. Cardiff University has a thriving and innovative research culture, with research that has real impact and makes a positive difference to the world. As part of this, the University is translating fundamental discoveries in disease processes to develop new medicines to meet unmet clinical needs. Cardiff University is looking for companies with an innovative outlook and recognised expertise in supporting drug-discovery projects from early screening (electrophysiology and in vitro DMPK) to delivering de-risked novel molecules to clinical trials. Successful companies will be committed to the principles of the NC3Rs and will add value to our work by providing high-quality data for informing the drug-discovery pipeline.",
"lots": [
{
"id": "1",
"title": "Electrophysiology Services",
"description": "We require providers for electrophysiology services relevant to neuroscience drug development. Currently we require validated ion channel assays for GABAA and NMDA modulators, on an automated electrophysiology platform, with QC and report generation. In the near future, it is likely we will require a range of other ion channel assays, as well as manual patch clamp services. We may also want to purchase ion channel expressing cell lines (under a MTA).",
"awardCriteria": {
"criteria": [
{
"name": "as per procurement docs",
"type": "quality",
"description": "100"
},
{
"type": "price",
"description": "0"
}
]
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "2",
"title": "In-vivo assays",
"description": "We require providers for in-vivo assays, most usually with oral administration. We currently require reliable assays for pro-cognitive and anxiolytic effects. In the future, we may require assays to demonstrate other drug modulated effects, such as, but not limited to, an anti-depressive effect.",
"awardCriteria": {
"criteria": [
{
"name": "as per procurement docs",
"type": "quality",
"description": "100"
},
{
"type": "price",
"description": "0"
}
]
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "3",
"title": "In-vitro drug metabolism (ADME-Tox) services",
"description": "We require providers of in-vitro drug metabolism (ADME-Tox) services as part of our drug development pipeline. This includes, but is not limited to, measures of metabolism, permeability and transporters, physicochemical properties, protein binding and toxicology.",
"awardCriteria": {
"criteria": [
{
"name": "as per procurement docs",
"type": "quality",
"description": "100"
},
{
"type": "price",
"description": "0"
}
]
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "4",
"title": "In-vivo pharmacokinetics (PK) and toxicology",
"description": "We require providers of in-vivo drug metabolism (ADME-Tox) services as part of our drug development pipeline.",
"awardCriteria": {
"criteria": [
{
"name": "as per procurement docs",
"type": "quality",
"description": "100"
},
{
"type": "price",
"description": "0"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
}
],
"deliveryAddresses": [
{
"region": "UKL22"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
}
],
"deliveryAddresses": [
{
"region": "UKL22"
}
],
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
}
],
"deliveryAddresses": [
{
"region": "UKL22"
}
],
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73111000",
"description": "Research laboratory services"
}
],
"deliveryAddresses": [
{
"region": "UKL22"
}
],
"relatedLot": "4"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
]
},
"awards": [
{
"id": "001039-2021-CU258-1",
"relatedLots": [
"1"
],
"title": "Electrophysiology Services",
"status": "unsuccessful",
"statusDetails": "discontinued"
},
{
"id": "001039-2021-CU258-2",
"relatedLots": [
"2"
],
"title": "In-vivo assays",
"status": "unsuccessful",
"statusDetails": "discontinued"
},
{
"id": "001039-2021-CU258-3",
"relatedLots": [
"3"
],
"title": "In-vitro drug metabolism (ADME-Tox) services",
"status": "unsuccessful",
"statusDetails": "discontinued"
},
{
"id": "001039-2021-CU258-4",
"relatedLots": [
"4"
],
"title": "In-vivo pharmacokinetics (PK) and toxicology",
"status": "unsuccessful",
"statusDetails": "discontinued"
}
],
"parties": [
{
"id": "GB-FTS-1902",
"name": "Cardiff University",
"identifier": {
"legalName": "Cardiff University"
},
"address": {
"streetAddress": "Procurement Services, McKenzie House, 30-36 Newport Road",
"locality": "Cardiff",
"region": "UKL",
"postalCode": "CF24 0DE",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 2920879648",
"email": "Buyline@cardiff.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers",
"buyerProfile": "https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0258",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-172",
"name": "European Union",
"roles": [
"funder"
]
},
{
"id": "GB-FTS-111",
"name": "High Court",
"identifier": {
"legalName": "High Court"
},
"address": {
"streetAddress": "Royal Courts of Justice, The Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 2079477501"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-1902",
"name": "Cardiff University"
},
"planning": {
"budget": {
"finance": [
{
"id": "1",
"description": "Call-off contracts under this framework may be financed by EU funds",
"financingParty": {
"name": "European Union",
"id": "GB-FTS-172"
},
"relatedLots": [
"1",
"2",
"3",
"4"
]
}
]
}
},
"links": [
{
"rel": "prev",
"href": "https://ted.europa.eu/udl?uri=TED:NOTICE:177464-2020:TEXT:EN:HTML"
}
],
"language": "en"
}